Preferences of lung cancer patients for treatment and decision-making : a systematic literature review
© 2015 John Wiley & Sons Ltd..
The consideration of patient preferences in decision-making has become more important, especially for life-threatening diseases such as lung cancer. This paper aims to identify the preferences of lung cancer patients with regard to their treatment and involvement in the decision-making process. We conducted a systematic literature review from 12 electronic databases and included studies published between 2000 and 2012. A total of 20 studies were included in this review. These revealed that lung cancer patients do have preferences that should be considered in treatment decisions; however, these preferences are not homogenous. We found that patients often consider life extension to be more important than the health-related quality of life or undesirable side effects. This preference seems to depend on patient age. Nausea and vomiting are the most important side effects to be avoided; the relevance of other side effects differs highly between subgroups. The majority of lung cancer patients, nevertheless, seem to prefer a passive rather than an active role in decision-making, although the self-reported preferences differed partly from the physicians' perceptions. Overall, we identified an urgent need for larger studies that are suitable for subgroup analyses and incorporate multi-attributive measurement techniques.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
European journal of cancer care - 25(2016), 4 vom: 26. Juli, Seite 580-91 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Schmidt, K [VerfasserIn] |
---|
Links: |
---|
Themen: |
Decision-making |
---|
Anmerkungen: |
Date Completed 10.04.2017 Date Revised 02.12.2018 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/ecc.12425 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM255648375 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM255648375 | ||
003 | DE-627 | ||
005 | 20231224174936.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/ecc.12425 |2 doi | |
028 | 5 | 2 | |a pubmed24n0852.xml |
035 | |a (DE-627)NLM255648375 | ||
035 | |a (NLM)26676876 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Schmidt, K |e verfasserin |4 aut | |
245 | 1 | 0 | |a Preferences of lung cancer patients for treatment and decision-making |b a systematic literature review |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.04.2017 | ||
500 | |a Date Revised 02.12.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2015 John Wiley & Sons Ltd. | ||
520 | |a The consideration of patient preferences in decision-making has become more important, especially for life-threatening diseases such as lung cancer. This paper aims to identify the preferences of lung cancer patients with regard to their treatment and involvement in the decision-making process. We conducted a systematic literature review from 12 electronic databases and included studies published between 2000 and 2012. A total of 20 studies were included in this review. These revealed that lung cancer patients do have preferences that should be considered in treatment decisions; however, these preferences are not homogenous. We found that patients often consider life extension to be more important than the health-related quality of life or undesirable side effects. This preference seems to depend on patient age. Nausea and vomiting are the most important side effects to be avoided; the relevance of other side effects differs highly between subgroups. The majority of lung cancer patients, nevertheless, seem to prefer a passive rather than an active role in decision-making, although the self-reported preferences differed partly from the physicians' perceptions. Overall, we identified an urgent need for larger studies that are suitable for subgroup analyses and incorporate multi-attributive measurement techniques | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a decision-making | |
650 | 4 | |a lung cancer | |
650 | 4 | |a patient | |
650 | 4 | |a preference | |
650 | 4 | |a systematic review | |
650 | 4 | |a treatment | |
700 | 1 | |a Damm, K |e verfasserin |4 aut | |
700 | 1 | |a Prenzler, A |e verfasserin |4 aut | |
700 | 1 | |a Golpon, H |e verfasserin |4 aut | |
700 | 1 | |a Welte, T |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European journal of cancer care |d 1993 |g 25(2016), 4 vom: 26. Juli, Seite 580-91 |w (DE-627)NLM075117835 |x 1365-2354 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2016 |g number:4 |g day:26 |g month:07 |g pages:580-91 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/ecc.12425 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 25 |j 2016 |e 4 |b 26 |c 07 |h 580-91 |